Skip to content

Effects of Age on Amino Acid Delivery to Tendon

Effects of Age on Amino Acid Delivery to Tendon

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04064528
Enrollment
20
Registered
2019-08-22
Start date
2019-09-06
Completion date
2023-08-01
Last updated
2023-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging

Keywords

amino acid, tendon, aging

Brief summary

Dietary amino acid supplementation may provide an effective means to promote tendon injury recovery and enhance collagen synthesis. While most published research has been completed in animal models, research with young adults has shown that a leucine-rich whey isolate consumed during a chronic resistance training (RT) intervention resulted in greater gains (\ 60%) in tendon CSA when compared to placebo. Leucine-rich diets have also improved tendon collagen content in rodents. Further, in our preliminary work utilizing microdialysis, we demonstrate that oral consumption of a leucine-rich amino acid beverage increased delivery of amino acids to tendons in young adults (21-30 years). However, whether aging alters the delivery of amino acids to tendons after oral consumption has not be investigated. In order to optimize amino acid dosing for chronic interventional studies, we wish to determine if aging influences amino acid concentration in the peritendinous (space around the tendon) space after oral consumption.

Interventions

DIETARY_SUPPLEMENTAmino Acids

10 g bolus of essential amino acids

Sponsors

Purdue University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Young (21-30 years old) and older (60-75 years) adults will each receive an oral bolus of 10 g of essential amino acids.

Eligibility

Sex/Gender
ALL
Age
21 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

\-

Exclusion criteria

* body mass index \>35 kg•m-2, those on medications known to affect protein or collagen metabolism, e.g. acetaminophen, ibuprofen, or prescription cyclooxygenase inhibitors, previous history of tendinopathy, or diabetes.

Design outcomes

Primary

MeasureTime frameDescription
Achilles Peritendinous Amino Acid Levels in young and older adults0-6 hours post consumptionConcentrations of amino acids will be measured from around the Achilles tendon

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026